KN-5502

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKN-5502

Drug Alias Nameallogeneic CAR-NK cell therapy (Rui Therapeutics)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionImmunomodulatorsNatural killer cells modulators

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesShenzhen Rui Therapeutics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Rui Therapeutics Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A